| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999647 | Urologic Oncology: Seminars and Original Investigations | 2015 | 9 Pages |
Abstract
In a cohort of patients who underwent RP, PHI is significantly better than PCA3 in the ability to predict the presence of both more aggressive and extended PCa.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Francesco M.D., Ph.D., Giorgio Ivan M.D., Matteo M.D., Antonio M.D., Ph.D., Sebastiano M.D., Vincenzo M.D., Sisto M.D., Danilo M.D., Daniela M.D., Ottavio M.D., Giuseppe M.D., Rocco M.D.,